1. Home
  2. ATRC vs DXPE Comparison

ATRC vs DXPE Comparison

Compare ATRC & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • DXPE
  • Stock Information
  • Founded
  • ATRC 2000
  • DXPE 1908
  • Country
  • ATRC United States
  • DXPE United States
  • Employees
  • ATRC N/A
  • DXPE N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • DXPE Industrial Machinery/Components
  • Sector
  • ATRC Health Care
  • DXPE Industrials
  • Exchange
  • ATRC Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • ATRC 1.6B
  • DXPE 1.9B
  • IPO Year
  • ATRC 2005
  • DXPE 1996
  • Fundamental
  • Price
  • ATRC $33.13
  • DXPE $86.12
  • Analyst Decision
  • ATRC Strong Buy
  • DXPE Buy
  • Analyst Count
  • ATRC 9
  • DXPE 1
  • Target Price
  • ATRC $52.00
  • DXPE $95.00
  • AVG Volume (30 Days)
  • ATRC 618.7K
  • DXPE 196.2K
  • Earning Date
  • ATRC 10-29-2025
  • DXPE 11-06-2025
  • Dividend Yield
  • ATRC N/A
  • DXPE N/A
  • EPS Growth
  • ATRC N/A
  • DXPE 36.17
  • EPS
  • ATRC N/A
  • DXPE 5.27
  • Revenue
  • ATRC $518,304,999.00
  • DXPE $1,959,889,000.00
  • Revenue This Year
  • ATRC $16.90
  • DXPE $10.99
  • Revenue Next Year
  • ATRC $12.29
  • DXPE $6.65
  • P/E Ratio
  • ATRC N/A
  • DXPE $16.22
  • Revenue Growth
  • ATRC 15.80
  • DXPE 12.76
  • 52 Week Low
  • ATRC $28.29
  • DXPE $67.31
  • 52 Week High
  • ATRC $43.11
  • DXPE $130.97
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 45.22
  • DXPE 27.31
  • Support Level
  • ATRC $31.12
  • DXPE $84.04
  • Resistance Level
  • ATRC $33.98
  • DXPE $100.59
  • Average True Range (ATR)
  • ATRC 1.80
  • DXPE 6.31
  • MACD
  • ATRC -0.00
  • DXPE -2.93
  • Stochastic Oscillator
  • ATRC 39.16
  • DXPE 5.33

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.

Share on Social Networks: